TP53 and ovarian serous carcinoma: The presence of a TP53 pathogenic variant has been shown to be a defining feature of high grade serous ovarian carcinoma (HGSC), with the Cancer Genome Atlas database showing 96% of cases of HGSC harbouring a TP53 pathogenic variant [56].